// App-Quantinova.ai

: COMPARISON OF TWO QPCR-BASED METHODS FOR MEASUREMENT OF MINIMAL RESIDUAL DISEASE IN B-PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA WITH THREE MAJOR FUSION TRANSCRIPTS

Researchers

Presenter

  • Ying-Jung Huang

Principal Investigators

  • Hsi-Che Liu

  • Ming-Chung Kuo

  • Tang-Her Jaing

  • Ting-Chi Yeh

  • Tung-Liang Lin

  • Shih-Hsiang Chen

  • Tung-Huei Lin

  • Ting-Yu Huang

  • Po-Nan Wang

  • Chao-Ping Yang

  • Lee-Yung Shih

Medical Centers

  • Chang Gung Memorial Hospital, Keelung, Taiwan, Province of China

  • Mackay Memorial Hospital,Taipei,Taiwan, Province of China

  • Chang Gung Memorial Hospital at Linkou,Taoyuan,Taiwan, Province of China;Chang Gung University,Taoyuan,Taiwan, Province of China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • B-cell acute lymphoblastic leukemia

Biomarkers

  • ETV6-RUNX1

  • T-cell receptor

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A